TY - JOUR
T1 - The significance of short latency in mesothelioma for attribution of causation
T2 - Report of a case with predisposing germline mutations and review of the literature
AU - Klebe, Sonja
AU - Hocking, Ashleigh J.
AU - Soeberg, Matthew
AU - Leigh, James
PY - 2021/12/2
Y1 - 2021/12/2
N2 - Malignant mesothelioma is a tumour of the serosal membranes, related to asbestos exposure. Median latency is in the order of 40 years in various registries, but small numbers of cases with shorter latencies have long been reported and often dismissed as unrelated to asbestos exposure. However, emerging data regarding the significance of inherited mutations leading to a predisposition to mesothelioma suggest that the causative effect of asbestos may be associated with shorter latencies in a subset of patients. Here, we describe a male patient with germline mutations in RAD51 and p53 who developed peritoneal mesothelioma 8.5 years after well-documented asbestos exposure and discuss the current literature on the subject. Mesothelioma in situ is now a WHO-accepted diagnosis, but preliminary data reveal a potential lead time of 5 or more years to invasive disease, and this is also a factor which may affect the recording of latency (and potentially survival) in the future.
AB - Malignant mesothelioma is a tumour of the serosal membranes, related to asbestos exposure. Median latency is in the order of 40 years in various registries, but small numbers of cases with shorter latencies have long been reported and often dismissed as unrelated to asbestos exposure. However, emerging data regarding the significance of inherited mutations leading to a predisposition to mesothelioma suggest that the causative effect of asbestos may be associated with shorter latencies in a subset of patients. Here, we describe a male patient with germline mutations in RAD51 and p53 who developed peritoneal mesothelioma 8.5 years after well-documented asbestos exposure and discuss the current literature on the subject. Mesothelioma in situ is now a WHO-accepted diagnosis, but preliminary data reveal a potential lead time of 5 or more years to invasive disease, and this is also a factor which may affect the recording of latency (and potentially survival) in the future.
KW - BAP1
KW - Genetic predisposition syndrome
KW - Latency
KW - Mesothelioma
KW - Mesothelioma in situ
KW - RAD51
KW - TP53
UR - http://www.scopus.com/inward/record.url?scp=85121300926&partnerID=8YFLogxK
U2 - 10.3390/ijerph182413310
DO - 10.3390/ijerph182413310
M3 - Review article
C2 - 34948918
AN - SCOPUS:85121300926
SN - 1661-7827
VL - 18
JO - International Journal of Environmental Research and Public Health
JF - International Journal of Environmental Research and Public Health
IS - 24
M1 - 13310
ER -